ALXO

ALX Oncology Holdings Inc
4.81
0.20 (4.34%)
Stock Name Stock Symbol Market Stock Type
ALX Oncology Holdings Inc ALXO NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
0.20 4.34% 4.81 07:21:42
Open Price Low Price High Price Close Price Previous Close
4.73 4.70 5.0691 4.81 4.61
more quote information »

Recent News

Date Time Source Heading
14/3/202323:00PRNUSALX Oncology and Quantum Leap Healthcare CollaborativeTM..
13/3/202323:02EDGARCurrent Report Filing (8-k)
13/3/202322:00GLOBEALX Oncology and Quantum Leap Healthcare Collaborative™..
10/3/202309:04EDGARSecurities Registration: Employee Benefit Plan (s-8)
10/3/202308:03EDGARCurrent Report Filing (8-k)
10/3/202308:01GLOBEALX Oncology Reports Fourth Quarter and Full Year 2022..
16/2/202323:00GLOBEALX Oncology Announces First Patient Dosed in ASPEN-07, a..
15/2/202308:19EDGARStatement of Ownership (sc 13g)
10/2/202300:25EDGARAmended Statement of Ownership (sc 13g/a)
05/1/202323:00GLOBEALX Oncology Provides Corporate Update and Highlights Key..
03/1/202323:00GLOBEALX Oncology to Present at the 41st Annual J.P. Morgan..
13/12/202202:00GLOBEALX Oncology Announces Initial Data from ASPEN-05 Study of..
29/11/202223:00GLOBEALX Oncology Appoints Scott Garland to its Board of..
09/11/202222:35TRMNH.C. Wainwright Sticks to Its Buy Rating for ALX Oncology..
09/11/202208:22EDGARQuarterly Report (10-q)
09/11/202208:05EDGARCurrent Report Filing (8-k)
09/11/202208:01GLOBEALX Oncology Reports Third Quarter 2022 Financial Results..
04/11/202200:00GLOBEALX Oncology to Present New Clinical Data on Evorpacept..
02/11/202222:00GLOBEALX Oncology Announces Upcoming Investor Conference..
31/10/202222:31EDGARCurrent Report Filing (8-k)
31/10/202222:00GLOBEALX Oncology Enters $100 Million Loan Facility Agreement..
05/10/202223:01GLOBEALX Oncology Announces Trials in Progress Abstracts Accepted..
22/9/202206:01GLOBEALX Oncology to Participate in the Cantor Oncology,..
01/9/202221:00GLOBEALX Oncology Announces Upcoming Investor Conference..
16/8/202223:54PRNUSALX Oncology and Quantum Leap Healthcare Collaborative™..
15/8/202221:00GLOBEALX Oncology and Quantum Leap Healthcare..
11/8/202221:00GLOBEALX Oncology Announces First Patient Dosed in Phase 2..
10/8/202222:11EDGARAmended Statement of Ownership (sc 13g/a)
10/8/202208:11EDGARStatement of Changes in Beneficial Ownership (4)
10/8/202208:08EDGARStatement of Changes in Beneficial Ownership (4)
10/8/202207:58EDGARStatement of Changes in Beneficial Ownership (4)
10/8/202207:56EDGARStatement of Changes in Beneficial Ownership (4)
09/8/202206:04EDGARCurrent Report Filing (8-k)
09/8/202206:01GLOBEALX Oncology Reports Second Quarter 2022 Financial Results..
01/8/202221:00GLOBEALX Oncology’s Evorpacept Receives Fast Track Designation..
29/6/202222:00DJNALX Oncology's Evorpacept Gets FDA Designation for Leukemia
29/6/202221:00GLOBEALX Oncology Receives U.S. FDA Orphan Drug Designation for..
11/6/202200:15EDGARSchedule 13g
(sc 13g/a)
08/6/202219:10TRMNH.C. Wainwright Reaffirms Their Buy Rating on ALX Oncology..
07/6/202219:40TRMNStifel Nicolaus Thinks ALX Oncology Holdings’ Stock is Going..
03/6/202221:00GLOBEALX Oncology Announces Evorpacept Clinical Program Updates
01/6/202221:00GLOBEALX Oncology to Participate in the Jefferies 2022 Healthcare..
28/5/202206:59EDGARPost-effective Amendment to Registration Statement (pos Am)
16/5/202220:16TRMNH.C. Wainwright Thinks ALX Oncology Holdings’ Stock is Going..
10/5/202206:18EDGARQuarterly Report (10-q)
10/5/202206:01GLOBEALX Oncology Reports First Quarter 2022 Financial Results..
22/4/202222:28EDGARProxy Statement (definitive) (def 14a)
15/4/202209:54EDGARStatement of Changes in Beneficial Ownership (4)
15/4/202209:50EDGARInitial Statement of Beneficial Ownership (3)
12/4/202222:35EDGARCurrent Report Filing (8-k)
Your Recent History
NASDAQ
ALXO
ALX Oncolo..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230321 23:55:05